- Home
- UUU vs APM Comparison
UUU vs APM Comparison
Compare UUU & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.88
HOLD
Current Price
$1.33
Company Overview
Basic Information| Metric | UUU | APM |
|---|---|---|
| Founded | 1969 | 2010 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6M | 10.7M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | UUU | APM |
|---|---|---|
| Price | $4.88 | $1.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 37.2K | ★ 105.6K |
| Earning Date | 11-19-2025 | 12-18-2025 |
| Dividend Yield | ★ 20.58% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $16,346,015.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.42 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.65 | $0.67 |
| 52 Week High | $8.27 | $7.49 |
Technical Indicators
Market Signals| Indicator | UUU | APM |
|---|---|---|
| Relative Strength Index (RSI) | 60.26 | 43.89 |
| Support Level | $4.00 | $1.30 |
| Resistance Level | $4.53 | $1.37 |
| Average True Range (ATR) | 0.28 | 0.10 |
| MACD | 0.11 | 0.01 |
| Stochastic Oscillator | 93.84 | 47.83 |
Price Performance
Historical Comparison UUU
APM
About UUU Universal Security Instruments Inc.
Universal Safety Products Inc is a U.S.-based importer and distributor of home safety devices such as ventilation fans and ground fault circuit interrupters.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.